Lumexa Imaging Holdings, Inc.
$9.65
▼
-0.53%
2026-04-21 07:55:01
www.lumexaimaging.com
NMS: LMRI
Explore Lumexa Imaging Holdings, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$928.42 M
Current Price
$9.65
52W High / Low
$19.45 / $7.23
Stock P/E
—
Book Value
$6.1
Dividend Yield
—
ROCE
1.69%
ROE
-12.6%
Face Value
—
EPS
$-0.66
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
4,064
Beta
—
Debt / Equity
164.22
Current Ratio
1.27
Quick Ratio
1.27
Forward P/E
9.25
Price / Sales
0.88
Enterprise Value
$1.8 B
EV / EBITDA
19.57
EV / Revenue
1.76
Rating
Strong Buy
Target Price
$20.43
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Leverage is relatively high.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Bioventus Inc. | $10.28 | 38.48 | $874.79 M | — | 10.76% | 13.17% | $10.76 / $5.81 | $2.74 |
| 2. | Globus Medical, Inc. | $96.1 | 24.49 | $13.01 B | — | 11.18% | 12.29% | $101.4 / $51.79 | $33.86 |
| 3. | IceCure Medical Ltd | $0.36 | — | $24.87 M | — | -166.53% | -1.89% | $1.4 / $0.28 | $0.12 |
| 4. | QuidelOrtho Corporation | $12.89 | — | $877.57 M | — | 1.14% | -46.15% | $38.99 / $11.61 | $28.28 |
| 5. | Pulsenmore Ltd. | $3.33 | — | $72.38 M | — | -33.09% | -17.62% | $1,468 / $1,000 | — |
| 6. | ClearPoint Neuro, Inc. | $11.16 | — | $349.74 M | — | -27.78% | -95.64% | $30.1 / $8.27 | $0.95 |
| 7. | Butterfly Network, Inc. | $5.49 | — | $1.39 B | — | -37.34% | -42.25% | $5.62 / $1.32 | $0.77 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q4 2024 | |
|---|---|---|
| Sales | 267.73 M | 248.03 M |
| Operating Profit | -7.47 M | -8.4 M |
| Net Profit | -28.69 M | -25.06 M |
| EPS in Rs | -0.3 | -0.26 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Sales | 1.02 B | 948.87 M | 935.92 M |
| Operating Profit | 26.73 M | -16.26 M | -12.83 M |
| Net Profit | -47.1 M | -94.1 M | -122.23 M |
| EPS in Rs | -0.49 | -0.98 | -1.27 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Total Assets | 1.76 B | 1.67 B | 1.67 B |
| Total Liabilities | 1.18 B | 1.51 B | 1.47 B |
| Equity | 586.12 M | 161.65 M | 198.43 M |
| Current Assets | 227.26 M | 172.52 M | 166.77 M |
| Current Liabilities | 179.19 M | 173.66 M | 161.12 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Operating CF | 17.07 M | 40.73 M | 37.51 M |
| Investing CF | -20.96 M | -22.28 M | -29.66 M |
| Financing CF | 36.58 M | -12.5 M | -8.77 M |
| Free CF | -6.4 M | 12.95 M | 13.51 M |
| Capex | -23.48 M | -27.77 M | -24.01 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue Growth % | 7.82% | 1.38% | — |
| Earnings Growth % | 49.94% | 23.01% | — |
| Profit Margin % | -4.6% | -9.92% | -13.06% |
| Operating Margin % | 2.61% | -1.71% | -1.37% |
| Gross Margin % | 15.4% | 10.15% | 10.57% |
| EBITDA Margin % | 13.85% | 12.01% | 10.1% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.